AU2020901506A0 - Compositions and their prophylactic or therapeutic use - Google Patents

Compositions and their prophylactic or therapeutic use

Info

Publication number
AU2020901506A0
AU2020901506A0 AU2020901506A AU2020901506A AU2020901506A0 AU 2020901506 A0 AU2020901506 A0 AU 2020901506A0 AU 2020901506 A AU2020901506 A AU 2020901506A AU 2020901506 A AU2020901506 A AU 2020901506A AU 2020901506 A0 AU2020901506 A0 AU 2020901506A0
Authority
AU
Australia
Prior art keywords
prophylactic
compositions
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020901506A
Inventor
Eleanor Jane Barnes
Senthil Kumar Chinnakannan
Heidi Drummer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
University of Oxford
Original Assignee
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
University of Oxford
Filing date
Publication date
Application filed by Macfarlane Burnet Institute for Medical Research and Public Health Ltd, University of Oxford filed Critical Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Publication of AU2020901506A0 publication Critical patent/AU2020901506A0/en
Priority to EP21804220.8A priority Critical patent/EP4149541A1/en
Priority to PCT/AU2021/050437 priority patent/WO2021226664A1/en
Priority to US17/924,646 priority patent/US20230181726A1/en
Priority to CN202180043193.7A priority patent/CN115843270A/en
Priority to CA3178547A priority patent/CA3178547A1/en
Priority to JP2022568765A priority patent/JP2023526045A/en
Priority to BR112022023101A priority patent/BR112022023101A2/en
Priority to AU2021270053A priority patent/AU2021270053A1/en
Assigned to MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED, CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD reassignment MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED Amend patent request/document other than specification (104) Assignors: MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED
Abandoned legal-status Critical Current

Links

AU2020901506A 2020-05-11 2020-05-11 Compositions and their prophylactic or therapeutic use Abandoned AU2020901506A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP21804220.8A EP4149541A1 (en) 2020-05-11 2021-05-11 A hepatitis c nucleic acid vaccine comprising a variable domain deleted e2 polypeptide
PCT/AU2021/050437 WO2021226664A1 (en) 2020-05-11 2021-05-11 A hepatitis c nucleic acid vaccine comprising a variable domain deleted e2 polypeptide
US17/924,646 US20230181726A1 (en) 2020-05-11 2021-05-11 A hepatitis c nucleic acid vaccine comprising a variable domain deleted e2 polypeptide
CN202180043193.7A CN115843270A (en) 2020-05-11 2021-05-11 Hepatitis C nucleic acid vaccine comprising E2 polypeptide deleted of variable domain
CA3178547A CA3178547A1 (en) 2020-05-11 2021-05-11 A hepatitis c nucleic acid vaccine comprising a variable domain deleted e2 polypeptide
JP2022568765A JP2023526045A (en) 2020-05-11 2021-05-11 Hepatitis C Nucleic Acid Vaccines Comprising Variable Domain Deleted E2 Polypeptides
BR112022023101A BR112022023101A2 (en) 2020-05-11 2021-05-11 COMPOSITION COMPRISING A NUCLEIC ACID MOLECULE ENCODING AN HCV VARIABLE DOMAIN E2 POLYPEPTIDE FOR USE IN THE TREATMENT OR PREVENTION OF HCV INFECTION, USE OF A NUCLEIC ACID MOLECULE ENCODING AN HCV VARIABLE DOMAIN E2 POLYPEPTIDE, AND METHOD FOR TREATMENT OR PREVENTION OF HCV INFECTION
AU2021270053A AU2021270053A1 (en) 2020-05-11 2021-05-11 A Hepatitis C nucleic acid vaccine encoding a variable domain deleted E2 polypeptide

Publications (1)

Publication Number Publication Date
AU2020901506A0 true AU2020901506A0 (en) 2020-05-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP3891267A4 (en) Microbial compositions comprising ellagitannin and methods of use
AU2022342169A1 (en) Hbb-modulating compositions and methods
AU2022344251A1 (en) Serpina-modulating compositions and methods
AU2020901506A0 (en) Compositions and their prophylactic or therapeutic use
EP3965776A4 (en) Oligosaccharide compositions and methods of use
AU2020902026A0 (en) Cosmetic and Therapeutic Compositions
AU2021902949A0 (en) Composition and use thereof
AU2020903242A0 (en) Composition and use thereof
AU2021902682A0 (en) Compositions and uses thereof
AU2021902267A0 (en) Compositions and uses thereof
AU2021901822A0 (en) Compositions and uses thereof
AU2020904491A0 (en) Compositions and uses thereof
AU2023903793A0 (en) Combination therapy and uses thereof
AU2023902434A0 (en) Combination therapy and uses thereof
AU2022401258A1 (en) Compositions and methods
AU2022342168A1 (en) Pah-modulating compositions and methods
AU2019903896A0 (en) Compositions and methods of use
EP4005574A4 (en) Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of l-dopa-induced dyskinesia
AU2023902974A0 (en) Composition and use thereof
AU2021900201A0 (en) Compositions and methods
AU2019904410A0 (en) Immunostimulatory compositions and use thereof
AU2020904390A0 (en) Compositions and methods
AU2022902659A0 (en) Composition and use thereof
AU2021902138A0 (en) Composition and uses thereof
AU2019902527A0 (en) Compositions and methods of use